Overview

Proof-of-concept Trial of Apraglutide in GVHD

Status:
Recruiting

Trial end date:
2025-08-30

Target enrollment:

Participant gender:

Summary

The aim of this trial is to assess safety and efficacy of apraglutide in subjects with steroid refractory gastrointestinal acute graft versus host disease (aGVHD).

Phase:

Phase 2

Details

Lead Sponsor:

VectivBio AG